Ngā hua rapu - Danbee Ha
- E whakaatu ana i te 1 - 4 hua o te 4
-
1
-
2
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody mā Danbee Ha, Atsushi Tanaka, Tatsuya Kibayashi, Atsushi Tanemura, Daisuke Sugiyama, James B. Wing, Ee Lyn Lim, Karen Wei Weng Teng, Dennis O. Adeegbe, Evan W. Newell, Ichiro Katayama, Hiroyoshi Nishikawa, Shimon Sakaguchi
I whakaputaina 2018Artigo -
3
PD-1<sup>+</sup>regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer mā Takahiro Kamada, Yosuke Togashi, Christopher Tay, Danbee Ha, Akinori Sasaki, Yoshiaki Nakamura, Eiichi Sato, Shota Fukuoka, Yasuko Tada, Atsushi Tanaka, Hiromasa Morikawa, Akihito Kawazoe, Takahiro Kinoshita, Kohei Shitara, Shimon Sakaguchi, Hiroyoshi Nishikawa
I whakaputaina 2019Artigo -
4
Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells mā Atsushi Tanaka, Hiroyoshi Nishikawa, Shinsuke Noguchi, Daisuke Sugiyama, Hiromasa Morikawa, Yoshiko Takeuchi, Danbee Ha, Naoya Shigeta, Toshio Heike, Yuka Maeda, Takuro Saito, Yoshinori Shinohara, Yoshihiro Kameoka, Keiko Iwaisako, Fumihiko Monma, Kohshi Ohishi, Julia Karbach, Elke Jäger, Kenichi Sawada, Naoyuki Katayama, Naoto Takahashi, Shimon Sakaguchi
I whakaputaina 2019Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Biochemistry
Biology
Cancer research
FOXP3
Immune system
Immunology
Antibody
CD8
Cancer
Cell biology
Cytotoxic T cell
In vitro
Internal medicine
Medicine
Monoclonal antibody
Allele
Antibody-dependent cell-mediated cytotoxicity
Antigen
Ataxia
Blockade
CTLA-4
Cancer cell
Cancer immunotherapy
Chronic myelogenous leukemia
Cytosol
Deferoxamine
Effector
Enzyme
Frataxin
Gene